Skip to content

BIOCLINEC

Active Private limited companyfounded 2010active for 16 yearsChemin des Vignerons 62, 5100 NamurKBO/BCE: BE 0830.852.213

Annual accounts 2025

micro format, filed on 30-06-2026, 31 days before the deadline
€412,117
▲ 11.2%
€410,936
▲ 11.2%
€320,025
▲ 2.4%
€1.5m
▲ 5.0%
81.9%
▼ 0.5 percentage points
5.53
▼ 0.16

Turnover is estimated at about €830,000, probably between €580,000 and €1.2m. The micro format does not state turnover.

Balance sheet

balance sheet total €1.8m on 31-12-2025
What the company ownsHow it is paid for

in €m

in euro

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend20252024202320222021202020192018201720162015201420132012201114 months
-----391,960362,847354,128375,321372,211353,649244,333297,290322,561366,620
-----281,679265,282235,875239,378239,704229,167162,590207,372219,970256,559
-----0001,54814,3870000367,750
31,12231,829-596,62911,826-601,622275,592229,207-161,434223,893173,831249,614152,546163,680152,965-
1.5m1.4m1.3m1.2m1.2m1.1m1.5m1.2m982,142933,092708,196479,878318,061134,118-98,791
81.9%82.4%82.5%82.1%80.8%60.5%95.0%92.1%78.4%89.1%83.9%82.6%78.2%70.8%48.6%
5.535.695.705.585.262.5420.3912.494.368.585.474.583.201.870.58
0.220.210.210.220.240.650.050.090.280.120.190.210.280.411.06
21.2%21.7%22.5%17.0%25.4%22.4%15.0%15.3%18.4%18.7%22.1%18.6%30.6%44.8%94.5%
17.3%17.9%18.6%14.0%20.6%13.5%14.2%14.1%14.4%16.7%18.6%15.4%23.9%31.7%45.9%

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend20252024202320222021202020192018201720162015201420132012201114 months
Balance sheet: assets
20/58 1.8m1.7m1.6m1.5m1.5m1.8m1.6m1.4m1.4m1.2m1.0m824,091708,500572,437460,841
21/28 50505050505032,92772,321111,714149,559174,050210,050246,050283,911322,561
21 ------30,00066,000102,000138,000174,000210,000246,000282,000318,000
22/27 ------2,8776,2719,66411,509---1,8614,511
24 ------2,8776,2719,66411,509---1,8614,511
28 505050505050505050505050505050
29/58 1.8m1.7m1.6m1.5m1.5m1.8m1.6m1.3m1.3m1.1m866,663614,041462,450288,526138,280
40/41 149,217194,547150,297156,987173,033168,163162,747168,107149,503155,237139,533136,526137,480127,236129,864
40 149,217194,547150,297142,414173,033168,163143,385147,787148,545155,237139,533112,099126,520126,106129,864
41 ---14,574--19,36220,320958--24,42710,9601,130-
50/53 1.4m1.2m1.2m473,594473,488199,999199,999188,616-------
54/58 344,745313,623281,794878,424866,5981.5m1.2m963,4211.1m900,961727,130477,516324,970161,2908,325
490/1 --------------90
Balance sheet: equity and liabilities
10/49 1.8m1.7m1.6m1.5m1.5m1.8m1.6m1.4m1.4m1.2m1.0m824,091708,500572,437460,841
10/15 1.5m1.4m1.3m1.2m1.2m1.1m1.5m1.3m1.1m1.1m873,458680,291553,701405,091223,770
10/11 14,26014,26014,26012,40012,40012,40012,40012,40012,400200,500200,500200,500200,50012,40012,400
100 ------18,60018,60018,600206,700206,700206,700206,70018,60018,600
101 ------6,2006,2006,2006,2006,2006,2006,2006,2006,200
13 1.5m1.4m1.3m1.2m1.2m1.1m1.5m1.3m1.1m866,670666,670479,200352,860391,860210,860
130/1 ---1,8601,8601,860120,000120,000120,000120,000120,000120,000---
130 ------20,67020,67020,67020,67020,6708,2001,8601,8601,860
1311 ---1,8601,8601,860---------
1319 ------120,000120,000120,000120,000120,000120,000---
133 1.5m1.4m1.3m1.2m1.2m1.1m1.3m1.1m921,000726,000526,000351,000351,000390,000209,000
14 47,93047,90545,42341,69140,66739,58319,47113,58212,1007,1156,288591341831510
17/49 333,571306,841286,334270,605290,742725,08879,760109,812299,901131,472167,255143,801154,799167,346237,070
42/48 333,571306,841286,334270,605287,803722,26276,278105,697292,215123,106158,467134,164144,388154,408237,070
44 1,3551,370--1,4571,5606451,42819192,5876207421,926
440/4 1,3551,370--1,4571,5606451,42819192,5876207421,926
45 10,9939,81715,729-12,7993,8657,873-2,5933,57338,933---19,131
450/3 8,3137,15415,729-10,2581,3307,873--3,57338,933---19,131
454/9 2,6792,663--2,5402,535--2,593------
47/48 321,223295,654270,605270,605273,548716,83668,399105,652288,194119,514119,514131,576143,768153,665216,013
492/3 ----2,9382,8263,4814,1157,6868,3668,7889,63710,41012,939-
Income statement
76A ---------4,577-----
9900 412,117370,538389,841392,299450,969392,980363,863355,142376,332373,337354,742244,905297,859323,124367,585
630 -----32,87739,39339,39339,39338,87736,00036,00037,86138,65045,189
640/8 1,1811,1441,1281,1121,0201,0191,0161,0141,0111,1261,093572569563965
9901 410,936369,394388,713391,187449,949359,083323,453314,735335,928333,334317,649208,333259,429283,911321,431
75/76B 35,05933,64313,12917,2666,1972,7023,4924,0779652,4353,5935001,011177196
75 35,05933,64313,12917,2666,1972,7023,4924,0779652,4353,5935001,011177196
65/66B -12,860-36,693-27,55879,2276,0373,007-7,72520,6297,7209,0039,60210,63411,74513,8621,097
65 -12,860-36,693-27,55879,2276,0373,007-7,72520,6297,7209,0039,60210,63411,74513,8621,097
9903 458,856439,730429,400329,226450,109358,778334,670298,183329,172326,765311,640198,199248,695270,226320,531
67/77 138,831127,247125,668118,202139,025109,976108,780101,701129,187125,938118,47271,60979,18588,906109,160
9904 320,025312,483303,732211,023311,084248,802225,889196,482199,985200,827193,167126,590169,510181,320211,370
9905 320,025312,483303,732211,023311,084248,802225,889196,482199,985200,827193,167126,590169,510181,320211,370
Appropriation of the result
9906 367,930357,905345,423251,691350,667268,273239,471208,582207,100207,115193,758126,931170,341181,831211,370
14P 47,90545,42341,69140,66739,583----------
791/2 247,500220,000195,000195,000200,000664,810------209,000--
691/2 320,000310,000300,000210,000310,000247,500220,000195,000195,000200,000187,470126,340170,000181,000210,860
6920 ----------12,4706,340--1,860
6921 320,000310,000300,000210,000310,000247,500220,000195,000195,000200,000175,000120,000170,000181,000209,000
694/7 247,500220,000195,000195,000200,000646,000------209,000--
694 247,500220,000195,000195,000200,000646,000------209,000--
Document PDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDF

The full notes are in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 30-06-2026.

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2025 micro format 30-06-2026 2026-00227642 PDF
31-12-2024 micro format 04-07-2025 2025-00240015 PDF
31-12-2023 micro format 15-07-2024 2024-00251472 PDF
31-12-2022 micro format 07-07-2023 2023-00220594 PDF
31-12-2021 micro format 07-07-2022 2022-20165613 PDF
31-12-2020 micro format 02-07-2021 2021-30500542 PDF
31-12-2019 micro format 29-06-2020 2020-23700244 PDF
31-12-2018 micro format 31-07-2019 2019-41500070 PDF
31-12-2017 micro format 06-07-2018 2018-30200566 PDF
31-12-2016 micro format 04-07-2017 2017-26500072 PDF
31-12-2015 full format 01-08-2016 2016-39100051 PDF
31-12-2014 full format 09-07-2015 2015-29100391 PDF
31-12-2013 full format 11-07-2014 2014-29300552 PDF
31-12-2012 full format 09-07-2013 2013-29100294 PDF
31-12-2011 full format 18-07-2012 2012-31100463 PDF

Insights on BIOCLINEC

The operating result for 2025 is 11% higher than in 2024 and the highest since 2021. It is a recovery after the fall in 2024.

Debt's share of the balance-sheet total rises from 17.6% to 18.1%. Equity and debt are higher.

Next steps